Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Healthcare & PharmaceuticalCompany Update

Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal

October 9, 2024 6:10 AM

Releaf, the UK's fastest-growing medical cannabis clinic, has joined forces with SOMAÍ Pharmaceuticals in an exclusive partnership aimed at revolutionizing patient care. Combining Releaf's industry-leading supply chain capabilities with SOMAÍ's advanced cannabis extracts, the collaboration is set to provide UK patients with exceptional, high-quality treatments. Tim Kirby - Releaf CEO (Left) & Michael Sassano - SOMAÍ CEO (Right)Releaf pride...

Read more
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Healthcare & PharmaceuticalCompany Update

Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal

October 9, 2024 6:10 AM

Releaf, the UK's fastest-growing medical cannabis clinic, has joined forces with SOMAÍ Pharmaceuticals in an exclusive partnership aimed at revolutionizing patient care. Combining Releaf's industry-leading supply chain capabilities with SOMAÍ's advanced cannabis extracts, the collaboration is set to provide UK patients with exceptional, high-quality treatments. Tim Kirby - Releaf CEO (Left) & Michael Sassano - SOMAÍ CEO (Right)Releaf pride...

Read more
Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal
Healthcare & PharmaceuticalCompany Update

Releaf & SOMAÍ Unite in Exclusive UK Cannabis Deal

October 9, 2024 6:10 AM

Releaf, the UK's fastest-growing medical cannabis clinic, has joined forces with SOMAÍ Pharmaceuticals in an exclusive partnership aimed at revolutionizing patient care. Combining Releaf's industry-leading supply chain capabilities with SOMAÍ's advanced cannabis extracts, the collaboration is set to provide UK patients with exceptional, high-quality treatments. Tim Kirby - Releaf CEO (Left) & Michael Sassano - SOMAÍ CEO (Right)Releaf pride...

Read more
Clinical Oncology Next-Generation Sequencing Market Set for Explosive Growth, Projected to Reach USD 3,131.5 Million by 2034 | Future Market Insights, Inc.
Healthcare & PharmaceuticalCompany Update

Clinical Oncology Next-Generation Sequencing Market Set for Explosive Growth, Projected to Reach USD 3,131.5 Million by 2034 | Future Market Insights, Inc.

October 9, 2024 6:00 AM

The global clinical oncology next-generation sequencing market is poised for unprecedented growth, with market size expected to surge from USD 635 million in 2024 to a staggering USD 3,131.5 million by 2034, at an impressive compound annual growth rate (CAGR) of 17.3%. This remarkable expansion underscores the pivotal role NGS technology plays in revolutionizing cancer diagnosis and treatment.A key factor fueling the market's rapid growth is the...

Read more
Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care
Healthcare & PharmaceuticalCompany Update

Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

October 9, 2024 4:20 AM

Diagnostic company SphingoTec GmbH ("SphingoTec") today announced a new partnership with Beckman Coulter Diagnostics Inc . ("Beckman Coulter"). Through this collaboration, the companies will bring an assay for SphingoTec's innovative kidney function biomarker, Proenkephalin 119-159 (penKid), to Beckman Coulter's extensive test menu for use on the Access Family of Immunoassay Analyzers. This alliance marks the first central laboratory license for...

Read more
Dr. Satjit Bhusri Sworn in as Honorary Police Surgeon for the NYPD
Healthcare & PharmaceuticalAwards

Dr. Satjit Bhusri Sworn in as Honorary Police Surgeon for the NYPD

October 8, 2024 5:05 PM

Dr. Satjit Bhusri, a renowned cardiologist and founder of Upper East Side Cardiology & Vein Institute, has been officially sworn in as an Honorary Police Surgeon for the New York City Police Department (NYPD). The ceremony, held at One Police Plaza, honors a select group of physicians known for their medical expertise and dedication to serving the NYPD. Dr. Bhusri, a leader in cardiac care, was nominated by an NYPD service member and...

Read more
Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024
Healthcare & PharmaceuticalCompany Update

Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024

October 8, 2024 4:15 PM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical and aesthetic skin diseases and conditions, today announced that the Company's CEO, Gerry Proehl, will present at the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group LLC, on Tuesday, October 15, 2024, at 3:30PM ET.Maxim Senior Analysts will host a wide range of biotechnology,...

Read more
Dr. John D. Anastasio Brings Clinical Expertise to AcutePet Urgent Care as Chief Veterinary Medical Officer
Healthcare & PharmaceuticalCompany Update

Dr. John D. Anastasio Brings Clinical Expertise to AcutePet Urgent Care as Chief Veterinary Medical Officer

October 8, 2024 2:00 PM

WEST CHESTER, OH / ACCESSWIRE / October 8, 2024 / AcutePet Urgent Care, a leader in veterinary urgent care, is thrilled to announce the appointment of John D. Anastasio, DVM, DACVECC as our Chief Veterinary Medical Officer.AcutePet Urgent Care CVMOJohn Anastasio, DVM, DACVECC AcutePet Urgent Care Chief Veterinary Medical Officer. Dr. Anastasio is a highly accomplished veterinarian with extensive experience in clinical emergency and critical care...

Read more
Quest Diagnostics Expands Access and Affordability of Diagnostic Services in 2023 With Enhanced Financial Assistance and Innovative Testing Solutions
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Quest Diagnostics Expands Access and Affordability of Diagnostic Services in 2023 With Enhanced Financial Assistance and Innovative Testing Solutions

October 8, 2024 1:40 PM

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / October 8, 2024 / We continued to grow access to and affordability of our leading diagnostic services over the past year. In 2023, we expanded utilization of our financial assistance program, widened availability of our services through new collaborations, and deepened our work with Q4HE.BROADENING AND SIMPLIFYING USE OF FINANCIAL...

Read more
Swap Health Announces Expansion of Leadership Team With Two Key Senior Leaders
Healthcare & PharmaceuticalManagement Changes

Swap Health Announces Expansion of Leadership Team With Two Key Senior Leaders

October 8, 2024 12:30 PM

Strategic Hires Strengthen Swap Health's Commitment to Scaling Clinical Quality and Expanding Partnerships with Health Systems NationwideNEW YORK, NY / ACCESSWIRE / October 8, 2024 / Swap Health, the outpatient nutrition solution of choice for primary care providers across the country, is pleased to announce the expansion of its leadership team by welcoming Joe Martinez as SVP Clinical Operations, and Josh Koch as VP Head of Partnerships.As Swap...

Read more
AGS Health Achieves Fourth Consecutive Recognition as a Leader in RCM Operations by Everest Group
Healthcare & PharmaceuticalAwards

AGS Health Achieves Fourth Consecutive Recognition as a Leader in RCM Operations by Everest Group

October 8, 2024 10:00 AM

AGS Health was recognized as a Leader in the Everest Group Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment for its vision, capability, and impact on the healthcare market.WASHINGTON, DC / ACCESSWIRE / October 8, 2024 / AGS Health, a leading provider of tech-enabled revenue cycle management (RCM) solutions and a strategic growth partner to healthcare providers across the U.S., has been named a Leader in Revenue Cycle Management...

Read more
Breast Cancer Awareness Month: Dr. Meegan Gruber Empowers Women Through Education, Prevention, and Hope
Healthcare & PharmaceuticalCompany Update

Breast Cancer Awareness Month: Dr. Meegan Gruber Empowers Women Through Education, Prevention, and Hope

October 8, 2024 9:45 AM

TAMPA, FL / ACCESSWIRE / October 8, 2024 / October is Breast Cancer Awareness Month, a time to shine a spotlight on one of the most pervasive and challenging health issues facing women today. As the country marks this month of awareness and advocacy, Dr. Meegan Gruber, a board-certified plastic surgeon and renowned expert in breast reconstructive surgery, is committed to empowering women with the knowledge they need to face breast cancer...

Read more
Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic
Healthcare & PharmaceuticalEnvironmental, Social and Governance

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

October 8, 2024 9:25 AM

NORTHAMPTON, MA / ACCESSWIRE / October 8, 2024 / In the early 2000s, Dr. Shannon Hader led the U.S. Centers for Disease Control and Prevention's collaboration with the Zimbabwe Ministry of Health that provided tens of thousands of people with much-needed HIV care.Shannon, a public health and infectious disease specialist, returned to the United States in 2006 to witness a vastly different situation in the nation's capital. Washington, D.C. was...

Read more
Lexaria Updates Current GLP-1 Market
Healthcare & PharmaceuticalCompany Update

Lexaria Updates Current GLP-1 Market

October 8, 2024 9:20 AM

KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, provides an update on recent glucagon-like peptide-1 ("GLP-1") receptor agonist market sector advancements.In 2020 the total market size for GLP-1 drugs was less than $4 billion . That same year, Novo Nordisk® paid $1.8 billion to purchase Emisphere's® SNAC drug...

Read more
Savista Discusses Projections for Healthcare Industry in Upcoming MGMA Webinar
Healthcare & PharmaceuticalCompany Update

Savista Discusses Projections for Healthcare Industry in Upcoming MGMA Webinar

October 8, 2024 9:15 AM

Chief Strategy Officer Laxmi Patel of Savista, a leading healthcare revenue management services company, will provide her predictions for the future of the healthcare industry in an upcoming Medical Group Management Association (MGMA) webinar on Oct. 30.The 60-minute webinar, titled, "Bold Predictions for the Future of Healthcare," will explore the technological advancements, changing patient expectations and evolving regulatory landscapes...

Read more
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
Healthcare & PharmaceuticalConferences

CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC

October 8, 2024 9:15 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, CEO of CNS Pharmaceuticals, will participate in a fireside chat at the 2024 Healthcare Virtual Summit, presented by Maxim Group LLC on October 16,2024 at 4:00 PM ET.Maxim Senior Analysts will...

Read more
Avenues Recovery Center to Open New 146-Bed Residential Addiction Treatment Facility in Baton Rouge
Healthcare & PharmaceuticalCompany Update

Avenues Recovery Center to Open New 146-Bed Residential Addiction Treatment Facility in Baton Rouge

October 8, 2024 9:00 AM

BATON ROUGE, LA / ACCESSWIRE / October 8, 2024 / Avenues Recovery Center is proud to announce the anticipated grand opening of its new, state-of-the-art residential addiction treatment facility in Baton Rouge, Louisiana. This 146-bed rehab center is designed to provide comprehensive and individualized care for those struggling with substance use disorders, offering a supportive and structured environment that fosters lasting recovery.Avenues...

Read more
 KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States
Healthcare & PharmaceuticalProduct Announcements

KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States

October 8, 2024 9:00 AM

KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced it is now contracted with United Healthcare Insurance Company, the largest healthcare insurance company in the United States.On November 1, 2024, KindlyMD will begin serving patients...

Read more
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
Healthcare & PharmaceuticalCompany Update

Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial

October 8, 2024 8:30 AM

SAN FRANCISCO, CA / ACCESSWIRE / October 8, 2024 / Jaguar Health, Inc.(NASDAQ:JAGX) ("Jaguar") today announced that a late-breaking abstract evaluating the incidence, severity and management of diarrhea from targeted therapies with or without standard chemotherapy in the cohort of adult patients with breast cancer in the placebo group of the OnTarget phase 3 study recently conducted by Jaguar family company Napo Pharmaceuticals, was submitted by...

Read more
The Global Biopharma Community is Now Actively Partnering for BIO-Europe(R) 2024
Healthcare & PharmaceuticalConferences

The Global Biopharma Community is Now Actively Partnering for BIO-Europe(R) 2024

October 8, 2024 8:15 AM

MUNICH, GERMANY / ACCESSWIRE / October 8, 2024 / The 30th annual BIO-Europe, the premier partnering conference for the global biopharmaceutical industry, is set to take place November 4-6, 2024, in Stockholm, Sweden.Partnering is in full swing with meeting requests showing an impressive 61% increase compared to the same point last year, while scheduled meetings have surged by a remarkable 96%. On top of one-to-one meetings, the event will cater...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?